Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
12 08 2022
Historique:
received: 24 10 2021
revised: 17 06 2022
accepted: 23 06 2022
pubmed: 16 7 2022
medline: 17 8 2022
entrez: 15 7 2022
Statut: ppublish

Résumé

Hesitancy to receive the COVID-19 vaccine among healthcare workers (HCWs) in low-resource settings, such as the Democratic Republic of the Congo (DRC), is a major global health challenge. This study identifies changes in willingness to receive vaccination among 588 HCWs in the DRC and reported influences on COVID-19 vaccination intentions. Up to 25 repeated measures were collected from participants between August 2020 to August 2021. Among the overall cohort, between August 2020 and mid-March 2021, the proportion of HCWs in each period of data collection reporting COVID-19 vaccine hesitancy ranged from 8.6% (95% CI: 5.97, 11.24) to 24.3% (95% CI: 20.12, 28.55). By early April 2021, the proportion reporting hesitancy more than doubled (52.0%; 95% CI: 46.22, 57.83). While hesitancy in the cohort began to decline by late-June 2021, 22.6% (95% CI: 18.05, 27.18) respondents indicated hesitancy in late-August 2021 which remains greater than the proportion of hesitancy at any time prior to early-March 2021. Patterns in reported influences on COVID-19 vaccination were varied with the proportion reporting some influences (e.g., no serious side effects, country of vaccine production) remaining stable throughout the year and other factors (e.g., recommendation of Ministry of Health, ease of vaccination) falling in popularity among respondents. Agreement that the national vaccination schedule should be followed apart from the COVID-19 vaccine remained high among respondents throughout the study period. This study shows that, among a cohort of HCWs in the DRC who have likely been influenced by regional, national, and global factors, COVID-19 vaccine hesitancy has fluctuated during the pandemic and should not be treated as a static factor. Additional research to determine which factors most influence HCWs' willingness to receive the COVID-19 vaccine offers opportunities to reduce vaccine hesitancy among this important population through tailored public health messaging.

Identifiants

pubmed: 35840471
pii: S0264-410X(22)00842-8
doi: 10.1016/j.vaccine.2022.06.077
pmc: PMC9247270
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4998-5009

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

JAMA. 2021 Feb 9;325(6):532-533
pubmed: 33372955
J Med Internet Res. 2020 Aug 10;22(8):e19611
pubmed: 32530816
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Int J Nurs Stud. 2011 Oct;48(10):1281-9
pubmed: 21474136
BMJ Open. 2021 Jan 18;11(1):e043356
pubmed: 33462101
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
J Med Internet Res. 2020 Oct 12;22(10):e21597
pubmed: 32960775
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1291-1293
pubmed: 34529642
Vaccines (Basel). 2021 Feb 14;9(2):
pubmed: 33672938
Psychol Sci Public Interest. 2012 Dec;13(3):106-31
pubmed: 26173286
Nat Rev Dis Primers. 2021 Jun 10;7(1):41
pubmed: 34112811
Nat Hum Behav. 2021 Mar;5(3):337-348
pubmed: 33547453
Vaccine. 2017 Oct 27;35(45):6059-6069
pubmed: 28974409
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Health Psychol. 2019 Nov;38(11):975-983
pubmed: 31259597
Int J Environ Res Public Health. 2021 Jan 19;18(2):
pubmed: 33477825
Nat Methods. 2013 Oct;10(10):921-2
pubmed: 24161969
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Vaccine. 2005 Feb 18;23(13):1574-8
pubmed: 15694509
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3
pubmed: 33684019
Int J Womens Health. 2011;3:313-7
pubmed: 21976985
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
J Public Health (Oxf). 2016 Dec 02;38(4):746-753
pubmed: 28158550

Auteurs

Angelica L Barrall (AL)

UCLA Fielding School of Public Health, Los Angeles, CA. Electronic address: abarrall@ucla.edu.

Nicole A Hoff (NA)

UCLA Fielding School of Public Health, Los Angeles, CA.

Dalau Mukadi Nkamba (DM)

Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DRC.

Kamy Musene (K)

UCLA-DRC Health Research and Training Program, Kinshasa, DRC.

Nicholas Ida (N)

UCLA Fielding School of Public Health, Los Angeles, CA.

Anna Bratcher (A)

UCLA Fielding School of Public Health, Los Angeles, CA.

Camille Dzogang (C)

UCLA-DRC Health Research and Training Program, Kinshasa, DRC.

Sylvia Tangney (S)

UCLA Fielding School of Public Health, Los Angeles, CA.

Michael Beia (M)

UCLA-DRC Health Research and Training Program, Kinshasa, DRC.

Michel Kabamba Nzaji (MK)

Expanded Programme for Immunization, Minister of Health, Kinshasa, DRC.

David Kampilu (D)

UCLA-DRC Health Research and Training Program, Kinshasa, DRC.

Gloire Mbaka Onya (G)

UCLA-DRC Health Research and Training Program, Kinshasa, DRC.

Christophe Luhata (C)

Expanded Programme for Immunization, Minister of Health, Kinshasa, DRC.

Adva Gadoth (A)

UCLA Fielding School of Public Health, Los Angeles, CA.

Elisabeth Mukamba Musenga (EM)

Expanded Programme for Immunization, Minister of Health, Kinshasa, DRC.

Placide Mbala (P)

National Institute of Biomedical Research, Kinshasa, DRC.

Didine Kaba (D)

Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DRC.

Anne W Rimoin (AW)

UCLA Fielding School of Public Health, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH